Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans

Metabolism: Clinical and Experimental

Volumn 61, Issue 8, 2012, Pages 1177-1181

  Juhl, Claus B ^a,b   Gjedsted, Jacob ^b   Nielsen, Michael F ^b   Schmitz, Ole ^b,c  

^a University of Esbjerg   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

BMI; body mass index; body weight; BW; FFA; free fatty acids; h; height; intravenous; iv; kg; kilogram; l; LBM; lean body mass; liter; min; minutes; mmol l; mmol liter; nanogram; ng; radio immune assay; RIA; t; time; U; unit

Indexed keywords

GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOSTATIN;

ADULT; ARTICLE; COMPARATIVE STUDY; COMPUTER SIMULATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; INFUSION; INSULIN RELEASE; MALE; NONPULSATILE INSULIN INFUSION; NORMAL HUMAN; PRIORITY JOURNAL; PULSATILE INSULIN INFUSION;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 2; EATING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; HUMAN GROWTH HORMONE; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PANCREATIC HORMONES; PITUITARY HORMONES; POSTPRANDIAL PERIOD; PULSATILE FLOW; RESEARCH DESIGN; TIME FACTORS;

EID: 84864277324     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.12.014     Document Type: Article

References (20)

1. M. Tominaga, H. Eguchi, and H. Manaka Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Diabetes Care 22 1999 920 924 (Pubitemid 29241045)
2. F. de Vegt, J.M. Dekker, and H.G. Ruhe Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study Diabetologia 42 1999 926 931 (Pubitemid 29369599)
3. D.R. Matthews, B.A. Naylor, and R.G. Jones Pulsatile insulin has greater hypoglycemic effect than continuous delivery Diabetes 32 1983 617 621 (Pubitemid 13062843)
4. P.R. Bratusch Marrain, M. Komjati, and W.K. Waldhausl Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans Diabetes 35 1986 922 926 (Pubitemid 16014446)
5. G. Paolisso, A.J. Scheen, and D. Giugliano Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency J Clin Endocrinol Metab 72 1991 607 615 (Pubitemid 21921738)
6. A.N. Peiris, J.I. Stagner, and R.L. Vogel Body fat distribution and peripheral insulin sensitivity in healthy men: role of insulin pulsatility J Clin Endocrinol Metab 75 1992 290 294
7. S.J. Hunter, A.B. Atkinson, and C.N. Ennis Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects Diabetes 45 1996 683 686 (Pubitemid 26140554)
8. K.S. Polonsky, B.D. Given, and E. Van Cauter Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects J Clin Invest 81 1988 442 448 (Pubitemid 18075238)
9. T.H. Hallynck, H.H. Soep, and J.A. Thomis Should clearance be normalised to body surface or to lean body mass? Br J Clin Pharmacol. 11 1981 523 526 (Pubitemid 11150198)
10. H. Orskov, H.G. Thomsen, and H. Yde Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone Nature 219 1968 193 195
11. N. Porksen, S. Munn, and J. Steers Effects of glucose ingestion versus infusion on pulsatile insulin secretion. The incretin effect is achieved by amplification of insulin secretory burst mass Diabetes 45 1996 1317 1323 (Pubitemid 26332892)
12. C. Juhl, T. Grofte, and P.C. Butler Effects of fasting on physiologically pulsatile insulin release in healthy humans Diabetes 51 Suppl 1 2002 S255 S257 (Pubitemid 34761524)
13. J.J. Meier, L.L. Kjems, and J.D. Veldhuis Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis Diabetes 55 2006 1051 1056 (Pubitemid 44100181)
14. C.B. Juhl, O. Schmitz, and S.M. Pincus Short-term treatment with GLP-1increases pulsatile insulin secretion in type II diabetes with no effect on orderliness Diabetologia 43 2000 583 588 (Pubitemid 30322076)
15. R. Ritzel, M. Schulte, and N. Porksen Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance Diabetes 50 2001 776 784 (Pubitemid 32242634)
16. B.A. Menge, L. Gruber, and S.M. Jorgensen Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes Diabetes 60 2011 2160 2168
17. C.B. Juhl, N. Porksen, and S.M. Pincus Acute and short-term admistration of a sulphonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes Diabetes 50 2001 1778 1784 (Pubitemid 33641596)
18. C.B. Juhl, M. Hollingdal, and J. Sturis Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes Diabetes 51 2002 424 429 (Pubitemid 34764798)
19. C.B. Juhl, N. Porksen, and M. Hollingdal Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency Diabetes Care 23 2000 675 681 (Pubitemid 30321550)
20. L.A. Weinrauch, J. Sun, and R.E. Gleason Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus Metabolism 59 2010 1429 1434